Screener
Medtronic MDT Business Segments
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Cardiovascular | $3.93B+19.5% | $3.8B+13.8% | $3.46B+13.8% | $3.44B+10.8% | $3.29B+9.2% | |
| Diabetes | $843M+16.9% | $838M+15.1% | $796M+14.7% | $757M+10.3% | $721M+11.4% | |
| Medical Surgical | $2.28B+9.9% | $2.39B+8.0% | $2.17B+4.9% | $2.17B+2.0% | $2.07B+3.9% | |
| Neuroscience | $2.68B+10.3% | $2.75B+5.0% | $2.56B+4.1% | $2.56B+4.5% | $2.43B+4.7% | |
| Other operating segment, misc | $29M-12.1% | —— | —— | —— | $33M-3.6% | |
| Net Sales by Geography | ||||||
| Ireland | $40M+21.2% | $39M+30.0% | $36M+28.6% | $35M+20.7% | $33M+10.0% | |
| Rest of world | $4.81B+11.3% | $4.9B+12.6% | $4.49B+11.4% | $4.41B+8.4% | $4.32B+13.6% | |
| UNITED STATES | $4.91B+16.1% | $4.87B+7.1% | $4.49B+6.0% | $4.52B+4.9% | $4.22B+3.5% |
FAQ
- How does Medtronic break its business down?
- Medtronic (MDT) reports net sales by business across 5 parts — Cardiovascular, Diabetes, Medical Surgical, Neuroscience and Other operating segment, misc. Each is extracted from the segment footnotes and tracked over time.
- Where does Medtronic's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Medtronic's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
